Arcus Biosciences Inc (RCUS) showcases a robust cash position and strategic collaborations, while navigating competitive ...

Arcus Biosciences, Inc. (NYSE:RCUS), a clinical-stage, global biopharmaceutical company focused on developing differentiated molecules and combination therapies for patients with cancer, today ...

High cholesterol can cause the arteries to harden and narrow, making it more difficult for blood to flow. In some cases, it ...

Around two in five people in the UK are thought to be living with high cholesterol, which is often dubbed a "silent killer".

Arcus Biosciences (NYSE:RCUS) is scheduled to announce Q1 earnings results on Tuesday, May 6th, after market close. The consensus EPS Estimate is -$1.01 and the consensus Revenue Estimate is $38.61M ( ...

ECURE, Inc., a gene editing company focused on the development of mutation-agnostic in vivo gene insertion therapies for the treatment of liver disorders with significant unmet need, today announced ...

Japan’s smaller companies could undergo a surge similar to that of its large-cap peers in recent years, but a weak yen is ...

Community Healthcare Trust Incorporated (the "Company") today announced a key leadership change to extend the Company's operational momentum and increase focus on portfolio leasing, management, and ...

De La Salle University has one goal as the UAAP Esports Valorant Tournament resumes — retain the title in its hands.

High cholesterol is a common health condition that can lead to serious complications, but there are ways to spot it without ...

After a back-to-back days of thunderstorms, we were treated to a beautiful sight as the sun set. As the storms moved out, a roll cloud moved in. Known for their low and horizontal cylindrical ...

Gilead and Arcus’ efforts to rebuild confidence in TIGIT as a drug target for cancer immunotherapies have shuffled forwards again, with new data showing signs of efficacy in a combination ...